Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 17 - Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
Patents for C07H 17 - Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals (11,681)
06/1999
06/16/1999EP0922460A1 Neuro-Function regulatory agent comprising glycosyl vitamin P
06/16/1999EP0922051A1 Process for the production of salts of erythromycin, roxithromycin, clarithromycin and azithromycin
06/16/1999EP0922050A1 3-descladinose-2,3-anhydroerythromycin derivatives
06/16/1999CN1219540A Chemical synthetic preparation method for new erythromycin A
06/16/1999CN1219539A 16-membered marcrolide derivatives and process for producing the same
06/15/1999US5912331 Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
06/15/1999US5912235 Ring-contracted n-demethyl-n-isopropyl-erythromycin-a-spiroacetal compounds, gastrointestinally effective motilin-agonistic properties
06/10/1999WO1999028333A1 Chemical synthesis of 6-o-alkyl erythromycin c
06/10/1999WO1999028332A1 6-o-alkyl erythromycin b oxime
06/10/1999WO1999028308A1 Antibiotics and process for preparation
06/10/1999WO1999027943A1 Use of ginkgo biloba extracts for preparing a medicine
06/10/1999CA2310003A1 Chemical synthesis of 6-o-alkyl erythromycin c
06/09/1999EP0920870A1 Flavanone-containing composition
06/09/1999EP0920312A1 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents
06/09/1999CN1218811A Novel seco compounds from the class of tylosins
06/02/1999EP0918783A1 6-o-substituted erythromycins and method for making them
05/1999
05/27/1999WO1999025723A1 Chemical synthesis of 6-o-alkyl erythromycin a
05/27/1999WO1999025722A1 Process for n-desmethylating erythromycins and derivatives thereof
05/27/1999WO1999025365A1 Use of ketolides for preparing arterial thrombotic complications related to atherosclerosis
05/27/1999CA2628019A1 Chemical synthesis of 6-o-alkyl erythromycin a
05/26/1999EP0707482B1 Erythromycin derivatives
05/26/1999EP0635019B1 Opiate derivatives and protein and polypeptide opiate derivative conjugates and labels
05/19/1999EP0915900A1 Process for the preparation of ivermectin
05/19/1999EP0915899A1 Preparation of crystal form ii of clarithromycin
05/19/1999EP0915898A1 Crystal form i of clarithromycin
05/18/1999US5905069 Methods of decreasing or preventing pain using spicamycin or derivatives thereof
05/18/1999US5905034 Method for precipitating natural avermectins
05/14/1999WO1999022722A2 Use of macrolides for the treatment of cancer and macular degeneration
05/14/1999CA2307850A1 Use of macrolides for the treatment of cancer and macular degeneration
05/12/1999EP0725786B1 Novel salts of amino glycosides
05/12/1999EP0722454B1 Stable solvates of avermectin compounds
05/06/1999WO1999021871A1 2-halo-6-o-substituted ketolide derivatives
05/06/1999WO1999021870A1 Erythromycin a 11, 12-carbamate derivatives
05/06/1999WO1999021869A1 Erythromycin a, 11,12-carbamate derivatives
05/06/1999WO1999021868A1 Erythromycin a derivatives
05/06/1999WO1999021867A1 Erythromycin a derivatives
05/06/1999WO1999021866A1 9-amino-3-keto erythromycin derivatives
05/06/1999WO1999021865A1 Tricyclic erythromycin derivatives
05/06/1999WO1999021864A1 6,11-bridged erythromycin derivatives
05/06/1999WO1999021550A1 Use of coumarin derivatives for the treatment of digestive tract disorders
05/06/1999WO1999011651A3 3-descladinose 6-o-substituded erythromycin derivatives
05/06/1999EP0912591A1 Novel method for isomerising the 10-methyl radical of erythromycin derivatives
05/06/1999CA2307828A1 6,11-bridged erythromycin derivatives
04/1999
04/29/1999WO1999020791A1 Method for suppressing multiple drug resistance in cancer cells
04/29/1999WO1999020639A2 NOVEL 3,6-HEMIKETALS FROM THE CLASS OF 9a-AZALIDES
04/29/1999WO1999020261A2 Use of antigunal agents for the topial treatment of fungus-induced mucositis
04/29/1999CA2307342A1 Method for suppressing multiple drug resistance in cancer cells
04/28/1999EP0910633A2 Polyketides and their synthesis
04/28/1999CN1215055A Sesquilterpenic internal ester compound for anti-ulcer of alimentary tract
04/27/1999CA2056823C Derivatives of 10,11,12,13-tetrahydrodesmycosin processes for preparation, and use thereof in pharmaceuticals
04/27/1999CA2018085C Alpha-glycosyl hesperidin, and its preparation and uses
04/22/1999WO1999019331A1 8a-azalides, compositions containing such compounds and methods of treatment
04/22/1999WO1999019319A1 Synthetic methods for polyphenols
04/22/1999CA2306851A1 Synthetic methods for polyphenols
04/21/1999EP0909327A2 Erythromycins and process for their preparation
04/20/1999CA2165806C Antiparasitic agents
04/15/1999WO1999018109A1 Ring e-modified analogues of (-)-podophyllotoxin and etoposide and a method for their synthesis
04/13/1999CA2173494C Process and antiparasitic intermediates for doramectin
04/08/1999WO1999016779A1 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity
04/08/1999WO1999016778A1 Cyclic phosphites and phosphates
04/08/1999WO1999003986A3 Method to produce polyketides and polyketides
04/08/1999WO1998054308A3 Polyketides and their synthesis and use
04/08/1999CA2304058A1 Cyclic phosphites and phosphates
04/08/1999CA2303930A1 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity
04/07/1999EP0906326A1 Novel aromatic derivatives substituted by a ribose, their method of preparation and application as medicine
04/07/1999CN1212882A Composition with comprises flavonoid and processed product of plant
04/06/1999US5892008 Protecting 2*-hydroxyl group of erythromycin a, reducing 9-keto group, protecting 9-hydroxy group, methylating 6-position, deprotecting, oxidizing 9-hydroxy group
04/06/1999US5891727 Acidic polycyclic ether useful as an anticoccidial agent and as a growth promotant
04/01/1999WO1999015166A1 Parasiticidal formulations
04/01/1999WO1999002541A3 Erythromycin a oxime solvates
04/01/1999CA2304283A1 Parasiticidal formulations
03/1999
03/31/1999CN1212700A Novel erythromycin derivatives, method for preparing same, and use thereof as drug
03/30/1999US5889164 Chromanol glycoside and method for production thereof
03/30/1999CA2168731C Antiparasitic agents
03/25/1999WO1999014225A1 Acetone adduct of antifungal agent v-28-3m
03/25/1999DE19742025A1 Use of flavone or flavanone derivatives to treat or prevent undesirable skin pigmentation
03/23/1999US5885969 Enzyme-treated hesperidin, process for producing the same and method of using enzyme-treated hesperidin
03/18/1999WO1999012947A1 6,9-bridged erythromycin derivatives
03/18/1999WO1999012946A1 9-hydrazone and 9-azine erythromycin derivatives and a process of making the same
03/18/1999WO1999012944A2 SYNTHETIC DIVALENT sLex CONTAINING POLYLACTOSAMINES AND METHODS FOR USE
03/18/1999WO1999012552A1 9a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
03/18/1999WO1999012542A1 8a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
03/18/1999CA2302470A1 Synthetic divalent slex containing polylactosamines and methods for use
03/18/1999CA2301643A1 6,9-bridged erythromycin derivatives
03/16/1999US5883236 Process for N-desmethylating erythromycins and derivatives thereof
03/16/1999US5883080 Antiparastic auermectin derivatives
03/16/1999CA2152819C New antiparasitic agents related to the milbemycins and avermectins
03/11/1999WO1999011651A2 3-descladinose 6-o-substituded erythromycin derivatives
03/11/1999CA2301642A1 3-descladinose 6-o-substituded erythromycin derivatives
03/10/1999EP0900230A2 Esculetin derivatives
03/10/1999EP0623137B1 Antiparasitic agents
03/04/1999WO1999010360A1 Oligosaccharide derivatives and process for producing the same
03/04/1999CA2301893A1 Oligosaccharide derivatives and process for producing the same
03/03/1999CN1209434A Melim sulfate compound
03/02/1999US5877310 Incubating a target material having a functional group and a glycoconjugated fluorescent compound of a fluorophore,a sugar and a reactive group for a period of time sufficient to react reactive group with functional group of the target
03/02/1999US5877208 Naringin and naringenin as 3-hydroxy-3-methylglutaryl CoA(HMG-CoA) reductase inhibitor
02/1999
02/25/1999WO1999009031A1 Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (hbv)
02/25/1999WO1999008687A1 13-deoxyanthracycline derivatives and processes for preparing them
02/24/1999CN1209134A Water soluble antibiotics
02/23/1999CA2171116C Substance it-62-b and medicinal composition containing the same
1 ... 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 ... 117